GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Omeros Corporation (OMER) [hlAlert]

Rating:
Buy OMER
up 125.78 %

Omeros (OMER) rated Buy by Canaccord Adams

Posted on: Tuesday,  Nov 17, 2009  8:25 AM ET by Canaccord Adams

Canaccord Adams rated Buy Omeros Corporation (NASDAQ: OMER) on 11/17/2009, when the stock price was $6.98. Since
then, Omeros Corporation has gained 125.79% as of 01/26/2016's recent price of $15.76.
If you would have followed this Canaccord Adams's recommendation on OMER, you would have gained 125.78% of your investment in 2261 days.

Omeros Corporation is a clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company?s clinically advanced product candidates are derived from its PharmacoSurgerytm platform designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Its PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/17/2009 8:25 AM Buy
None
6.98
as of 12/31/2009
1 Week down  -2.77 %
1 Month up  2.79 %
3 Months down  -0.28 %
1 YTD down  -0.28 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy